Last reviewed · How we verify
Boron-based Gel (Fibore)
Boron-based gel promotes wound healing and tissue repair through antimicrobial and anti-inflammatory properties.
Boron-based gel promotes wound healing and tissue repair through antimicrobial and anti-inflammatory properties. Used for Wound healing and tissue repair.
At a glance
| Generic name | Boron-based Gel (Fibore) |
|---|---|
| Also known as | Fibore |
| Sponsor | Tabriz University of Medical Sciences |
| Modality | Small molecule |
| Therapeutic area | Dermatology/Wound Care |
| Phase | Phase 3 |
Mechanism of action
Boron compounds have demonstrated antimicrobial activity against various pathogens and can modulate inflammatory responses in wound healing. The gel formulation allows for topical delivery to facilitate tissue regeneration and reduce infection risk in wound care applications.
Approved indications
- Wound healing and tissue repair
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Boron-based Gel (Fibore) CI brief — competitive landscape report
- Boron-based Gel (Fibore) updates RSS · CI watch RSS
- Tabriz University of Medical Sciences portfolio CI